Enasidenib is a 1,3,5-triazine compound that acts as an inhibitor of isocitrate dehydrogenase 2 (IDH2). It is used as an active pharmaceutical ingredient in the manufacturing of medicines for certain hematologic malignancies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Enasidenib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Enasidenib mesylate
pharmaceutical raw material
Acoramidis
pharmaceutical raw material
Olmesartan
pharmaceutical raw material
Olmesartan medoxomil
pharmaceutical raw material
Telmisartan
pharmaceutical raw material
The international HS code for Enasidenib (CAS 1446502-11-9) is 2933.69.
2933.69
2933 69 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol
DYLUUSLLRIQKOE-UHFFFAOYSA-N
CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O
Sourcing Enasidenib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.